Studies of chitosan/Kollicoat SR 30D film-coated tablets for colonic drug delivery

被引:40
作者
Fan Li-Fang [2 ,3 ]
He Wei [1 ,4 ]
Chang Yong-Zhen [7 ,8 ]
Xiang Bai [1 ]
Du Qing [1 ]
Wang Feng [5 ]
Qin Min [6 ]
Cao De-Ying [1 ]
机构
[1] Hebei Med Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Shijiazhuang, Peoples R China
[2] Hebei Med Univ, Sch Pharmaceut Sci, Dept Pharmaceut Anal, Shijiazhuang, Peoples R China
[3] Inst Med, Hebei Yiling Pharmaceut Grp, Beijing, Peoples R China
[4] CSPC Pharmaceut Technol Co Ltd, Shijiazhuang, Peoples R China
[5] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Dept Hepatitis, Beijing, Peoples R China
[6] Liuzhou Worker Hosp, Dept Gastroenterol, Liuzhou, Peoples R China
[7] XingTai Med Coll, XingTai Med Sch Facial Feature, Dept Pharmaceut, Xingtai, Peoples R China
[8] XingTai Med Coll, Med Treatment Tech Fac, Xingtai, Peoples R China
关键词
Chitosan; Kollicoat SR30D; Film coating; Colonic delivery; Pharmacokinetics; IN-VITRO EVALUATION; 5-AMINOSALICYLIC ACID; TARGETED DELIVERY; CHITOSAN; RELEASE; AMYLOSE; PELLETS; VIVO; POLYSACCHARIDES; BACTERIA;
D O I
10.1016/j.ijpharm.2009.03.023
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
The aim of the study was to define in vitro and in vivo characteristics of chitosan/Kollicoat SR30D film-coated tablets of theophylline for colonic delivery. The tablet cores were coated to different film thicknesses with blends of Kollicoat SR30D and chitosan (2.51, 3.5:1, and 5:1, w/w). Swelling and drug release studies were carried out in simulated gastric fluid, simulated intestinal fluid and simulated colonic fluid, respectively. The mechanism of drug release was determined using the Korsmeyer-Peppas model. The in vivo degradation of the tablets was also studied in rats. The swelling behavior and drug release depended on the composition of the coating, as well as the ratio of Kollicoat SR30D to chitosan. The coating was susceptible to enzymatic action, and more accessible to bacterial enzymes than beta-glucosiclase enzyme. The extent of swelling and digestion correlated with the amount of chitosan within the coating. The drug release data fit well into the Korsmeyer-Peppas equation, indicating that the drug release was controlled by polymer relaxation. The in vivo pharmacokinetic studies of the coated tablets showed delayed T-max, decreased C-max and prolonged MRT. Chitosan/Kollicoat SR30D coated tablets could deliver the drug to the targeted site for local action. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:8 / 15
页数:8
相关论文
共 45 条
[1]
The use of scintigraphy to provide ''proof of concept'' for novel polysaccharide preparations designed for colonic drug delivery [J].
Adkin, DA ;
Kenyon, CJ ;
Lerner, EI ;
Landau, I ;
Strauss, E ;
Caron, D ;
Penhasi, A ;
Rubinstein, A ;
Wilding, IR .
PHARMACEUTICAL RESEARCH, 1997, 14 (01) :103-107
[2]
Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery [J].
Akhgari, A. ;
Farahmand, F. ;
Garekani, H. Afrasiabi ;
Sadeghi, F. ;
Vandamme, T. F. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 28 (04) :307-314
[3]
The use of formulation technology to assess regional gastrointestinal drug absorption in humans [J].
Basit, AW ;
Podczeck, F ;
Newton, JM ;
Waddington, WA ;
Ell, PJ ;
Lacey, LF .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 21 (2-3) :179-189
[4]
HYDROGELS FOR SITE-SPECIFIC ORAL-DRUG DELIVERY - SYNTHESIS AND CHARACTERIZATION [J].
BRONDSTED, H ;
KOPECEK, J .
BIOMATERIALS, 1991, 12 (06) :584-592
[5]
Polysaccharides for colon targeted drug delivery [J].
Chourasia, MK ;
Jain, SK .
DRUG DELIVERY, 2004, 11 (02) :129-148
[6]
In vivo studies of amylose- and ethylcellulose-coated [C-13]glucose microspheres as a model for drug delivery to the colon [J].
Cummings, JH ;
Milojevic, S ;
Harding, M ;
Coward, WA ;
Gibson, GR ;
Botham, RL ;
Ring, SG ;
Wraight, EP ;
Stockham, MA ;
Allwood, MC ;
Newton, JM .
JOURNAL OF CONTROLLED RELEASE, 1996, 40 (1-2) :123-131
[7]
FECAL MICROBIAL-FLORA IN 7TH-DAY-ADVENTIST POPULATIONS AND CONTROL SUBJECTS [J].
FINEGOLD, SM ;
SUTTER, VL ;
SUGIHARA, PT ;
ELDER, HA ;
LEHMANN, SM ;
PHILLIPS, RL .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1977, 30 (11) :1781-1792
[8]
Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin:: Results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients [J].
Gamelin, É ;
Boisdron-Celle, M ;
Delva, R ;
Regimbeau, C ;
Cailleux, PE ;
Alleaume, C ;
Maillet, ML ;
Goudier, MJ ;
Sire, M ;
Person-Joly, MC ;
Maigre, M ;
Maillart, P ;
Fety, R ;
Burtin, P ;
Lortholary, A ;
Dumesnil, Y ;
Picon, L ;
Geslin, J ;
Gesta, P ;
Danquechin-Dorval, E ;
Larra, F ;
Robert, J .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) :1470-1478
[9]
Mechanistic analysis of drug release from theophylline pellets coated by films containing pectin, chitosan and Eudragit® RS [J].
Ghaffari, Alireza ;
Avadi, Mohammad Reza ;
Moghimi, Hamid Reza ;
Oskoui, Mahvash ;
Bayati, Khosrow ;
Rafiee-Tehrani, Morteza .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2008, 34 (04) :390-402
[10]
Phosphated crosslinked guar for colon-specific drug delivery II. In vitro and in vivo evaluation in the rat [J].
Gliko-Kabir, I ;
Yagen, B ;
Baluom, M ;
Rubinstein, A .
JOURNAL OF CONTROLLED RELEASE, 2000, 63 (1-2) :129-134